As of January 22, 2025, Biohit Oyj (BIOBV.HE) has a market cap of $48.728 million USD. According to our data, Biohit Oyj is ranked No.8176 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $48.73 M |
67.28%
|
Dec 29, 2024 | $29.13 M |
21.49%
|
Dec 28, 2023 | $23.98 M |
20.06%
|
Dec 29, 2022 | $19.97 M |
-14.44%
|
Dec 29, 2021 | $23.34 M |
-26.01%
|
Dec 29, 2020 | $31.55 M |
-26.19%
|
Dec 29, 2019 | $42.74 M |
13.51%
|
Dec 27, 2018 | $37.65 M |
-21.49%
|
Dec 28, 2017 | $47.95 M |
-37.69%
|
Dec 29, 2016 | $76.96 M |
7.84%
|
Dec 29, 2015 | $71.36 M |
22.76%
|
Dec 29, 2014 | $58.13 M |
-33.31%
|
Dec 29, 2013 | $87.16 M |
95.36%
|
Dec 30, 2012 | $44.62 M |
44.51%
|
Dec 29, 2011 | $30.88 M |
39.52%
|
Dec 30, 2010 | $22.13 M |
40.00%
|
Dec 29, 2009 | $15.81 M |
18.11%
|
Dec 29, 2008 | $13.38 M |
-19.11%
|
Dec 27, 2007 | $16.54 M |
-22.66%
|
Dec 28, 2006 | $21.39 M |
-5.58%
|
Dec 29, 2005 | $22.66 M |
4.37%
|
Dec 30, 2004 | $21.71 M |
-17.60%
|
Dec 30, 2003 | $26.34 M |
77.30%
|
Dec 30, 2002 | $14.86 M |
-67.06%
|
Dec 30, 2001 | $45.10 M |
-30.97%
|
Dec 28, 2000 | $65.33 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Thermo Fisher Scientific
TMO
|
$220.26 B |
-0.000 M
|
USA
|
Agilent Technologies
A
|
$43.70 B |
0.000 M
|
USA
|
Danaher
DHR
|
$177.06 B |
-0.004 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$9.93 B |
1.815 B
|
USA
|
Illumina
ILMN
|
$22.95 B |
0.542 B
|
USA
|
Qiagen
QGEN
|
$10.61 B |
48.896 M
|
Netherlands
|
Waters Corporation
WAT
|
$24.37 B |
-0.198 B
|
USA
|
Bruker
BRKR
|
$9.10 B |
-1.516 M
|
USA
|
Merck KGaA
MRK.DE
|
$65.52 B |
46.041 B
|
Germany
|
Sartorius
SRT.DE
|
$16.32 B |
9.238 B
|
Germany
|
Mettler-Toledo
MTD
|
$27.91 B |
-0.040 B
|
USA
|
Shimadzu
7701.T
|
$8.23 B |
0.116 B
|
Japan
|
Market Cap | = | BIOBV.HE Stock Price | * | BIOBV.HE Shares Outstanding |
= | $3.21 | * | 12.21 M | |
= | $48.73 M |